The recent death of Abdel Baset al Megrahi, the convicted Lockerbie bomber, three years after his release from prison in Scotland has drawn an interesting Wall Street Journal editorial explaining why he lived so long after the initial prognosis that he only had three months to live.
According to the Journal, the doctor who made the initial estimate explained that his estimate was based upon the National Health Service medical treatment in Scotland, where certain standard chemotherapy treatments were not available because of their cost. In contrast, Mr. Megrahi undoubtedly obtained excellent treatment in Libya, where he could receive better chemotherapy.
The Journal draws the obvious conclusion that, unconstrained by government conclusions on cost-effectiveness, Mr. Megrahi lived almost 3 years longer than he would have in the Scottish, highly regulated, medical environment. The potential for similar results to occur in the United States under Obama care is obvious.
Showing posts with label National Health Service. Show all posts
Showing posts with label National Health Service. Show all posts
Subscribe to:
Posts (Atom)
Posts
